Wound care management involves dressings, equipment, and other aids, such as bandages, gels, and ostomy drainage bags, designed to prevent and treat wounds, as well as to promote or accelerate wound healing. Wound Debridement Devices are special devices used to remove dead or unhealthy tissue from a wound to promote healing. GlobalData uses proprietary data and analytics to provide a comprehensive report on the wound debridement devices devices market, including market shares of different players within the US. Buy the latest report here.
In 2023, GlobalData’s Market Model methodology determined that the leading player in the wound debridement devices market in the US was Smith & Nephew followed by Stryker, Zimmer Biomet, C. R. Bard and Lohmann & Rauscher.
Debridement can be done by various methods, for example Autolytic Wound Debridement Devices (which include wet to dry dressings), Enzymatic Debridement (which are ointments contain enzymatic agents), Mechanical Debridement, Hydrosurgery Debridement Devices, Low Frequency Ultrasound Devices, Surgical Debridement Devices, and Maggot Therapy. Autolytic Wound Debridement Devices, Surgical Debridement Devices, Enzymatic Debridement Agents and Maggot Therapy are not tracked here.
The value of the wound debridement devices devices market within the US was expected to be over $20m in 2023.
For the latest complete market share analysis of wound debridement devices device market in the US, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.